ArticleSkeletal radiology2026
CT-guided radiofrequency ablation in the treatment of pediatric and adult osteoid osteoma: single center experience and comparative results.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo report a single-center experience comparing the efficacy and safety of computed tomography (CT)-guided radiofrequency ablation (RFA) in the treatment of osteoid osteoma (OO) in pediatric and adult patients. MATERIALS AND
methodsThe electronic medical records of 97 patients who underwent CT-guided RFA for OO between January 2019 and January 2025 were retrospectively reviewed. Patients were divided into pediatric and adult groups. Demographic data, anatomical location and size of the lesion, procedure duration, pre- and post-procedure visual analog scale (VAS) scores, complications, technical and clinical success rates, and recurrence rates were evaluated.
resultsOf the 97 patients, 51 (52.6%) were pediatric and 46 (47.4%) were adults. The mean lesion diameter was 7.98 ± 2.92 mm in the pediatric group and 7.14 ± 3.72 mm in the adult group. The overall technical success rate of CT-guided RFA for OO was 100%, with primary and secondary clinical success rates of 97.9% and 98.9%, respectively. The primary clinical success rate was 98.1% (50/51) in the pediatric group and 97.8% (45/46) in the adult group. No major complications related to the procedure were observed. Minor complications included transient skin burn in one pediatric patient (1.9%, 1/51) and localized muscle pain in one pediatric (1.9%, 1/51) and one adult (2.2%, 1/46) patient.
conclusionThis study demonstrates that percutaneous CT-guided RFA is a highly effective and safe technique with high success and low complication rates for the treatment of OO in both pediatric and adult populations.
Indexed as
Identifiers
41076495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.